Follistatin Peptide Buy

Sourcing Laboratory-Grade Follistatin Peptides for Research

When executing a follistatin peptide buy for experimental protocols, principal investigators must ensure that the material meets strict analytical parameters. Follistatin is an autocrine glycoprotein expressed across diverse tissues, primarily recognized in biochemical literature for its high-affinity binding to members of the Transforming Growth Factor-beta (TGF-β) superfamily. In laboratory environments, researchers study Follistatin to elucidate its regulatory roles in cellular differentiation, muscle hypertrophy signaling, and tissue remodeling.

To achieve reproducible data in cell culture and preclinical models, research facilities must acquire reference compounds that are free of organic contaminants, residual reagents, or microbial pyrogens. PX1 Research provides laboratory-grade Follistatin-344 synthesized under strict quality controls. Researchers evaluating options across our catalog of research peptides can access lot-specific documentation that verifies structural sequence, purity, and mass-to-charge ratios before commencing in vitro assays.

Molecular Characteristics and Follistatin Isoforms

Follistatin (FST) exists in multiple distinct isoforms resulting from alternative mRNA splicing and post-translational proteolysis. Understanding these molecular variants is crucial when designing experimental frameworks or purchasing recombinant or synthetic proteins for laboratory study.

The primary full-length precursor gene encodes a 344-amino acid protein (FST-344). Downstream proteolytic cleavage of FST-344 gives rise to the circulating isoform FST-315, as well as the membrane-associated isoform FST-288. In cellular assays, FST-288 demonstrates an extremely high affinity for cell-surface heparin-sulfate proteoglycans due to its exposed basic C-terminal domain. Conversely, FST-315 contains a acidic C-terminal tail that neutralizes heparin binding, allowing it to circulate freely in systemic assays. FST-344 functions primarily as a precursor that undergoes tissue-specific cleavage, making it a highly versatile candidate for recombinant expression and localized cellular interaction studies.

Biochemical Mechanism: TGF-β Superfamily and Myostatin Antagonism

The biological interest surrounding Follistatin stems predominantly from its potent inhibitory activity against endogenous ligands within the TGF-β superfamily, most notably Activin A, Activin B, and Myostatin (Growth Differentiation Factor 8 / GDF-8). In vitro binding assays demonstrate that Follistatin forms an irreversible, high-affinity complex with these ligands, preventing them from engaging their cognate cell-surface receptors.

Under physiological conditions, Myostatin signals through a heterodimeric receptor complex consisting of Activin Type II receptors (ActRIIA or ActRIIB) and Type I alk receptors (ALK4 or ALK5). Binding triggers the intracellular phosphorylation of receptor-regulated Smad proteins (Smad2 and Smad3), which subsequently complex with Smad4 to translocate into the nucleus. This canonical pathway upregulates gene transcription profiles that suppress protein synthesis and promote muscle tissue catabolism. By sequestering extracellular Myostatin and Activins, Follistatin blunts Smad2/3 phosphorylation cascades, offering a validated model for investigating negative regulators of muscle mass and cellular proliferation in preclinical research.

Preclinical Literature and In Vitro Investigation Findings

Preclinical studies across various animal models have characterized the phenotypic consequences of Follistatin overexpression and recombinant administration. In rodent models, transgene-mediated overexpression of Follistatin or targeted knockout of the Myostatin gene yields significant increases in skeletal muscle mass without adverse organomegaly when localized correctly.

In vitro data indicate that incubating cultured myoblasts (such as C2C12 cell lines) with exogenous Follistatin antagonizes exogenous GDF-8, suppressing downstream gene expression related to atrophy (such as MuRF1 and MAFbx). Furthermore, researchers investigating fibrous tissue formation have observed that Follistatin blunts Activin A-induced expression of collagen and extracellular matrix components in fibroblast cultures. These findings make Follistatin a standard reference molecule when investigating pulmonary fibrosis models, hepatic stellate cell activation, and myogenesis regulation in cellular bioassays.

Quality Verification: Analytical Standards for Supplier Evaluation

Before finalizing a follistatin peptide buy, research institutions must establish strict quality criteria for vendor selection. Because peptide synthesis and recombinant protein expression can introduce impurities—including truncated sequences, deletion peptides, residual trifluoroacetic acid (TFA), and bacterial endotoxins—relying on unverified sources introduces significant experimental noise.

PX1 Research maintains an uncompromising standard for chemical integrity. Every batch of peptide synthesized for our inventory undergoes independent verification at an ISO 17025-accredited laboratory within the United States. Researchers can review our published analytical COA documentation prior to purchase to confirm that the material meets analytical thresholds for research applications.

Analytical Testing Protocols: RP-HPLC, Mass Spectrometry, and Endotoxin Testing

To guarantee that every vial of Follistatin meets laboratory standards, PX1 Research employs a three-tier analytical verification framework for every production lot:

1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Measures chemical purity by separating the target peptide from synthesis side-products and degradation species. PX1 Research mandates a purity threshold of ≥98.0% for research compounds.

2. Electrospray Ionization Mass Spectrometry (ESI-MS) / MALDI-TOF: Confirms molecular weight and sequence identity. Mass spectral analysis ensures that the observed mass matches the theoretical molecular weight within tight atomic mass unit (amu) tolerances, excluding incorrect sequence assembly or uncleaved protecting groups.

3. Chromogenic Limulus Amebocyte Lysate (LAL) Assay: Quantifies bacterial endotoxin contamination. For cellular assays, high endotoxin levels introduce inflammatory signals that confound experimental outcomes. PX1 Research products are batch-tested to ensure endotoxin content remains strictly below research-grade thresholds (<0.01 EU/µg).

In Vitro Handling, Reconstitution, and Storage Protocol

Proper handling and storage are critical to preserve the secondary structure and biological activity of Follistatin peptides in a laboratory setting. Lyophilized proteins are sensitive to thermal degradation, moisture intrusion, and shear stress.

Upon receipt, lyophilized Follistatin vials should be stored at -20°C or -80°C for long-term stability. Prior to opening, vials must be allowed to equilibrate to room temperature inside a desiccated chamber to prevent atmospheric moisture condensation on the cake.

Reconstitution should be performed using sterile Bacteriostatic Water, Sterile Water for Injection, or an appropriate low-pH assay buffer (such as dilute acetic acid or phosphate-buffered saline containing 0.1% BSA) as required by the experimental protocol. Direct high-speed vortexing should be avoided; gentler inversion or micro-centrifugation is recommended to fully solubilize the protein. Once reconstituted, liquid aliquots should be stored at -80°C to minimize freeze-thaw cycles, which can cause protein aggregation and activity loss.

Comparative Analysis: Follistatin vs. Alternative Myostatin Pathway Modulators

Researchers evaluating pathways that regulate muscle growth and cellular differentiation frequently compare Follistatin to other targeted ligands within the TGF-β axis. Understanding the structural differences among these research tools allows investigators to select the precise antagonist for their specific model.

While Follistatin-344 acts as a broad-spectrum trap binding Activin A, Activin B, and Myostatin, alternative research peptides offer distinct ligand specificity. For instance, Myostatin Propeptide represents the endogenous pro-domain that specifically inhibits GDF-8 without significant cross-reactivity to Activin pathways. Similarly, soluble receptor constructs such as Ace-031 utilize an engineered ActRIIB-Fc fusion protein to act as a decoy receptor for Myostatin and BMP ligands. Researchers evaluating metabolic and anabolic signaling cascades also frequently benchmark these myostatin inhibitors alongside cell-culture growth factors like IGF-1 DES to study synergistic signaling downstream of receptor tyrosine kinases and Smad complexes.

Procurement and Sourcing for Institutional and Wholesale Laboratories

PX1 Research streamlines compound acquisition for academic, biotechnology, and institutional research labs. Facilities conducting high-throughput screening or multi-phase animal studies can leverage our wholesale peptide accounts to secure consistent, single-lot batches that eliminate batch-to-batch variability across multi-week studies.

All orders are processed and shipped directly from our USA facilities located in California and Arizona. Orders placed Monday through Friday ship same-day, ensuring rapid cold-chain or standard transport delivery to maintain product stability from our laboratory to yours.